8-K//Current report
Quince Therapeutics, Inc. 8-K
Accession 0001193125-25-159886
$QNCXCIK 0001662774operating
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:30 PM ET
Size
186.8 KB
Accession
0001193125-25-159886
Documents
- 8-Kd71020d8k.htmPrimary
8-K
- EX-99.1d71020dex991.htm
EX-99.1
- EX-101.SCHqncx-20250716.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABqncx-20250716_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREqncx-20250716_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg71020g0716235906723.jpg
GRAPHIC
- GRAPHICg71020g22m25.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-159886-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd71020d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001662774
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:30 PM ET
- Size
- 186.8 KB